Weissella confusa
Intervention1 paper3 findings
- Human trial1
Outcomes
3Visceral fat area
downin humans1Moderate certainty
1 study
Visceral fat area
downin humans1Moderate certainty
Weissella confusa decreases visceral fat area in humans.
Human trialoverweight1.0 × 1010 colony-forming units/day12 weeks
Effects of Wilac D001 (Weissella confusa WIKIM51) Supplementation on Metabolic Parameters and Central Adiposity in Overweight Adults: A 12-Week Randomized, Double-Blind, Placebo-Controlled Trial · Journal of microbiology and biotechnology · 2 Sep 2026
Triglyceride
downin humans1Moderate certainty
1 study
Triglyceride
downin humans1Moderate certainty
Weissella confusa decreases triglyceride in humans.
Human trialoverweight1.0 × 1010 colony-forming units/day12 weeks
Effects of Wilac D001 (Weissella confusa WIKIM51) Supplementation on Metabolic Parameters and Central Adiposity in Overweight Adults: A 12-Week Randomized, Double-Blind, Placebo-Controlled Trial · Journal of microbiology and biotechnology · 2 Sep 2026
Fasting blood glucose
downin mice1Moderate certainty
1 study
Fasting blood glucose
downin mice1Moderate certainty
Weissella confusa decreases fasting blood glucose in mice.
Animalsin high-fat diet-fed mice10 weeksmales
Effects of Wilac D001 (Weissella confusa WIKIM51) Supplementation on Metabolic Parameters and Central Adiposity in Overweight Adults: A 12-Week Randomized, Double-Blind, Placebo-Controlled Trial · Journal of microbiology and biotechnology · 2 Sep 2026